Related references
Note: Only part of the references are listed.IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
N. Gachard et al.
LEUKEMIA (2013)
BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
Qingguo Yan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Molecular pathogenesis of Waldenstrom's macroglobulinemia
Esteban Braggio et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment
F. van Maldegem et al.
LEUKEMIA (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Waldenstrom macroglobulinemia: 2011 update on diagnosis, risk stratification, and management
Morie A. Gertz
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
Andrea Rinaldi et al.
BLOOD (2011)
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1
Lucy S. Hodge et al.
BLOOD (2011)
Distinctive Clinical and Histological Features of Waldenstrom's Macroglobulinemia and Splenic Marginal Zone Lymphoma
Luca Arcaini et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Oncogenic MYD88 mutation drives Toll pathway to lymphoma
Yogesh S. Jeelall et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
Aldo M. Roccaro et al.
BLOOD (2010)
SNP array analysis in hematologic malignancies: avoiding false discoveries
Stefan Heinrichs et al.
BLOOD (2010)
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine O'Keefe et al.
BLOOD (2010)
Pathophysiology of Waldenstrom's macroglobulinemia
Marvin J. Stone et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia
Esteban Braggio et al.
CANCER RESEARCH (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Targeting NF-κB in Waldenstrom macroglobulinemia
Xavier Leleu et al.
BLOOD (2008)
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia
Allen W. Ho et al.
BLOOD (2008)
Pivotal Advance:: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
Maria Loiarro et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Establishment of BCWM.1 cell line for Waldenstrom's macroglobulinemia with productive in vivo engraftment in SCID-hu mice
Daniel Ditzel Santos et al.
EXPERIMENTAL HEMATOLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
N. C. Gutierrez et al.
LEUKEMIA (2007)
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
Wee J. Chng et al.
BLOOD (2006)
Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma
EM Ocio et al.
CLINICAL LYMPHOMA (2005)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)